[Chances for the success of cytokine therapy in metastatic renal cell cancer].
Kriegmair
M
M
Urol. Univ.-Klinik, Klinikum Grosshadern, München.
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D009362:Neoplasm Metastasis; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D016898:Interferon-alpha; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha